Moreover, Barmann et al. confirmed that the reduced FECH activity in EPP patients was sufficient to increase the transcription of ALAS2 mRNA (Barman-Aksozen et al., 2019). This evidence concerns the gene ALAS2 and autosomal erythropoietic protoporphyria.